Halo340B today called on Federally Qualified Health Centers and other 340B covered entities to take a more strategic and mission-driven approach to understanding their 340B gross-to-net performance.
MiBolsilloColombia on MSN
The 340B Controversy: Understanding CMSs Proposal to Align Drug Payments with Costs
CMS Administrator Dr. Oz proposes deep cuts to the 340B drug program to lower Medicare costs. Learn how this affects ...
A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.
CMS proposes deeper 340B drug payment cuts for hospitals, reshaping outpatient cancer economics, consolidation incentives, and patient cost-sharing. The Centers for Medicare & Medicaid Services (CMS) ...
The rule, released Thursday, builds on Trump administration priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of ...
“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...
This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price. Payers have struggled with the increasing ...
Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the Health, Education, Labor and Pensions Committee appear to agree that ...
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...
On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...
Opinion
8don MSNOpinion
Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs
An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks the beginning of a financial one. Many of the 50 million Americans living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results